Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 9/20 | 0.42 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 5/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6619456 | 0.88 | MIF (0.41) | MIFNOTUMKDM1AMAOAMAOB | |
| SCHEMBL6528832 | 0.86 | MIF (0.39) | MIFNOTUMKDM1AKCNH2SIGMAR1 | |
| SCHEMBL6528802 | 0.83 | NOTUM (0.41) | MIFNOTUMKDM1ASIGMAR1 | |
| SCHEMBL6529873 | 0.83 | MIF (0.38) | MIFNOTUMKDM1AMAOAMAOB | |
| SCHEMBL6527406 | 0.83 | MIF (0.37) | MIFNOTUMKDM1A | |
| SCHEMBL6528828 | 0.81 | P2RY14 (0.38) | MIFNOTUMMAOAMAOBP2RY14 | |
| SCHEMBL6527844 | 0.81 | MIF (0.36) | MIFNOTUMKDM1AMAOAMAOB | |
| SCHEMBL5624193 | 0.77 | NOTUM (0.53) | MIFNOTUMKDM1AMAOAMAOB | |
| SCHEMBL5624151 | 0.77 | MAOA (0.43) | MIFNOTUMKDM1ASIGMAR1MAOA | |
| SCHEMBL5622623 | 0.76 | NOTUM (0.52) | MIFNOTUMKDM1ASIGMAR1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005082892-A2 | TRIAZOLE COMPOUNDS AS ANTIBACTERIAL AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DR. REDDY'S LABORATORIES LTD. (IN) | 2005-09-09 | — | — | WO | disclosed |